Aerpio pharmaceuticals, inc. (ARPO)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
License revenue, and other

-

-

-

-

-

2

18,821

1,333

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating expenses
Research and development

1,829

2,129

2,844

2,264

5,586

5,248

4,346

4,228

4,028

-

2,942

3,169

-

1,993

3,481

2,903

2,989

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Formation costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

General and administrative

2,285

1,540

2,160

2,799

3,255

3,619

3,277

3,140

3,447

-

1,814

2,414

-

1,312

1,264

1,473

1,215

5,847

4

5

3

9

4

5

4

8

4

5

4

8

4

5

4

8

5

5

4

4

5

Restructuring (benefit) expense

-

-

-38

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restructuring expense

-

-

-

915

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total operating expenses

4,114

4,657

4,966

5,978

8,841

8,868

7,623

7,369

7,476

6,288

4,756

5,583

4,759

3,305

4,745

4,377

4,205

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss from operations

-4,114

-4,657

-4,966

-5,978

-8,841

-8,866

11,198

-6,036

-7,476

-6,288

-4,756

-5,583

-4,759

-3,305

-4,745

-4,377

-4,205

-17,473

-4

-5

-3

-9

-4

-5

-4

-8

-4

-5

-4

-8

-4

-5

-4

-8

-5

-5

-4

-4

-5

Grant income

79

43

79

4

15

-

6

-

-

-

46

11

-

15

26

80

8

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest income

116

167

239

290

333

347

333

46

51

-

59

52

-

-227

-166

-88

1

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other income, net

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total other income

196

211

318

295

348

347

339

46

51

53

106

63

-236

-212

-140

-7

10

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2

2

1

1

1

1

1

1

1

1

1

1

1

1

1

0

0

0

0

0

0

Net and comprehensive loss

-3,918

-4,446

-4,647

-5,683

-8,492

-8,518

11,537

-5,989

-7,425

-6,235

-4,649

-5,520

-4,995

-3,517

-4,885

-4,385

-4,194

-17,050

-6

-7

-5

-11

-6

-6

-5

-9

-6

-6

-6

-9

-6

-6

-5

-8

-6

-6

-5

-4

-5

Net and comprehensive loss per share
Net and comprehensive loss

-3,918

-4,446

-4,647

-5,683

-8,492

-8,518

11,537

-5,989

-7,425

-6,235

-4,649

-5,520

-4,995

-3,517

-4,885

-4,385

-4,194

-17,050

-6

-7

-5

-11

-6

-6

-5

-9

-6

-6

-6

-9

-6

-6

-5

-8

-6

-6

-5

-4

-5

Extinguishment of preferred stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

224

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Adjustment of redeemable convertible preferred stock to redemption value

-

-

-

-

-

-

-

-

-

0

0

0

943

1,054

1,054

1,028

1,015

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss attributable to common stockholders

-

-

-

-

-

-8,518

-

-

-

-6,235

-4,649

-5,520

-5,939

-4,572

-5,940

-5,189

-5,210

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Basic and diluted

-0.10

-0.11

-0.11

-0.14

-0.21

-0.21

0.28

-0.22

-0.27

0.41

-0.17

-0.21

-1.06

-4.46

-6.69

-6.30

-7.07

-31.14

0.00

0.00

0.00

-0.01

0.00

0.00

0.00

-0.01

0.00

0.00

0.00

-0.01

0.00

0.00

0.00

-0.01

0.00

0.00

0.00

0.00

0.00

Weighted average number of common shares used in computing net and comprehensive loss per share
Basic

40,588

-

40,588

-

40,588

-

40,527

-

-

-

26,926

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Diluted

40,588

-

40,588

-

40,588

-

40,961

-

-

-

26,926

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Weighted average number of common shares used in computing net loss per share attributable to common stockholders, basic and diluted

-

40,588

-

40,588

-

-

-

27,340

27,045

-

-

26,895

5,605

962

888

823

737

-12,762

5,000

5,000

5,000

5,000

5,000

5,000

5,000

5,000

5,000

5,000

5,000

5,000

5,000

5,000

5,000

-

5,000

5,000

-

-

-

Weighted-average number of common shares outstanding (in shares)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5,000

5,000

5,000